My WebLink
|
Help
|
About
|
Sign Out
02
City of Pleasanton
>
BOARDS AND COMMISSIONS
>
ECONOMIC VITALITY
>
AGENDA PACKETS
>
2019
>
051619
>
02
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/3/2019 12:04:50 PM
Creation date
5/13/2019 3:06:33 PM
Metadata
Fields
Template:
CITY CLERK
CITY CLERK - TYPE
AGENDA REPORT
DOCUMENT DATE
5/16/2019
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
44
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
Show annotations
View images
View plain text
Thriving Sectors: Life Sciences <br />Life science and cloud software companies <br />have consistently attracted the majority of <br />venture capital investments in the last ten <br />years and continued to do so in 2o18. Over <br />30% of capital raised since 2o16 has gone <br />to life science companies, with over 20 <br />companies raising more than $555 million. <br />The majority of this capital was devoted to a <br />few later -staged companies, although many <br />earlier staged companies received funding <br />as well, With 22 deals rounds of funding <br />raised in amounts less than $25 million. <br />Within Life Sciences, the Tri -Valley fosters <br />exceptional companies in the device <br />space, benefiting from accommodative real <br />estate and a diverse talent pool required <br />as they grow. 98% of life science deals in <br />2o18 were in the medical device space. <br />Notable Life Science Investments <br />2018 <br />lox Genomics <br />$50WDebt <br />2018 <br />BioClin (Rainier Therapeutics) <br />$50m <br />2018 <br />Providence Medical Tech <br />$25M <br />2o18 <br />Unchained Labs <br />$17M <br />2018 <br />SafeTraces <br />$10M <br />2017 <br />Ankon Medical Tech <br />$loom <br />2017 <br />Purigen Biosystems <br />$21M <br />2017 <br />POC Medical Systems <br />$21M <br />2016 <br />HealthTell <br />$26M <br />2016 <br />Spirosure <br />$18M <br />23 <br />$250 <br />$200 <br />$150 <br />$100 <br />$50 <br />0 <br />Diagnostic Genomics Surgical Drug Biotechnology <br />Tools Devices Discovery <br />Life Science Segments <br />($M) <br />Series D <br />Genomics platform <br />Pleasanton <br />Series B <br />Drug discover <br />San Ramon <br />Late Stage <br />Cervical spine surgical device <br />Pleasanton <br />Series D <br />Laboratory instruments <br />Pleasanton <br />Series A <br />Edible barcode technology <br />Pleasanton <br />Late Stage <br />Gastric diagnostic device <br />Pleasanton <br />Series A <br />DNA sample prep <br />Pleasanton <br />Series A <br />Point -of -care cancer diagnostics <br />Livermore <br />Series B <br />Immune profiling <br />San Ramon <br />Series C <br />Breath -analysis disease <br />Pleasanton <br />diagnostics <br />
The URL can be used to link to this page
Your browser does not support the video tag.